Overview

Changes in Cytokine Levels After Dextrose Injection in Stage IV Knee Osteoarthritis

Status:
Unknown status
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
Twenty participants with severe arthritis will be enrolled. For the first week participants will either be injected with dextrose or just have fluid withdrawn for testing. The remaining participants will be given dextrose injection at the end of the week. After one week dextrose injections will be given at one, two, three, four, five, and six months. Fluid will be withdrawn from the knee at time zero, one week, and three months. The hypothesis is that dextrose injection will cause a change in proteins in the knee consistent with improved repair signals, along with improving knee pain and function. .
Phase:
N/A
Details
Lead Sponsor:
Fisiatria y Traumatología
Collaborator:
American Association of Orthopaedic Medicine